Tecovirimat Monohydrate + Repaglinide Interaction
Moderateinteraction on record
Description
TPOXX increases repaglinide concentration. Monitor blood glucose and hypoglycemic symptoms when co-administered.
Mechanism
Tecovirimat is a weak inhibitor of CYP2C8, which metabolizes repaglinide
Source: NLP:tecovirimat monohydrate